HUTCHMED (China) Limited
HUTCHMED (China) Limited (HCM) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
hcm · stock forecast · 10 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 10 Wall Street analysts in the past 3 months
Buy
10 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$13.60
Consensus
$13.60
+25.9% upside
Low
$13.60
Median: $13.6 · Last Close: $10.80
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $10.30 | ↓ 4.67% |
1-day model range: $10.25–$10.34. Peak: $10.34 (-4.67%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $9 | -17.1% |
| 2028 | $8 | -24.9% |
| 2029 | $8 | -28.8% |
| 2030 | $7 | -30.8% |
| 2031 | — | -31.9% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · HCM · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-10 | B of A Securities | Maintains | Buy→Buy |
| 2025-09-22 | Morgan Stanley | Downgrade ↓ | Equal Weight→Underweight |
| 2025-07-22 | B of A Securities | Maintains | Buy→Buy |
| 2024-08-01 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2023-11-24 | Deutsche Bank | Upgrade ↑ | Hold→Buy |
| 2023-11-10 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2023-09-05 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2023-07-24 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2022-08-09 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2022-08-02 | Goldman Sachs | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on HUTCHMED (China) Limited (HCM) stock. Of the recent 20 rating actions, 1 were upgrades and 2 were downgrades. 10 analysts currently cover HCM.
Analyst Recommendation Trends
HCM analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$639M
↓ 23.4% YoY
Revenue Next Year
$738M
↑ 15.4% YoY
EPS This Year
$0.32
EPS Next Year
$0.45
↑ 40.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast HCM EPS of $0.32 for the current fiscal year, based on estimates from 4 analysts. The HCM revenue forecast is $639M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The HCM stock forecast is supported by two independent data sources: analyst consensus ratings from 10 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus HCM price target is $13.60 (+25.9% upside), with an analyst consensus of Buy.
The HCM short-term stock prediction for tomorrow is $10.30 (-4.67%). The HCM stock price prediction for 2027 estimates an average of $9. The HCM stock prediction for 2030 projects a range of $7–$8.
HUTCHMED (China) Limited trades on NASDAQ under the ticker HCM. The HCM stock outlook for 2027 is broadly positive, supported by a Buy consensus among 80% of covering analysts.
Frequently asked questions
HCM forecast · 8 questionsAccording to 10 Wall Street analysts, the average 12-month HCM price target is $13.60, with a high forecast of $13.60 and a low of $13.60. The median price target is shown in the chart above when available. This implies +25.9% potential upside from the current price of $10.80.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.